Intrathecal triple

DRUG2 trials

Sponsors

Nordic Society for Pediatric Hematology and Oncology, Joanna Yi

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaPediatric AML

Early Phase 1

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

RecruitingNCT07059975

Joanna YiAcute Myeloid Leukemia, Pediatric AML

Start: 2025-10-22End: 2031-08-31Target: 36Updated: 2025-11-04

Phase 3

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

SuspendedNCT00991744

Nordic Society for Pediatric Hematology and OncologyAcute Lymphoblastic Leukemia

Start: 2009-01-31End: 2018-12-31Target: 100Updated: 2012-10-10

Related Papers

Update AML: Updated disease monitoring and treatment to enhance outcomes for pediatric AML (NCT07059975)

Blood2025-11-03